|
Jun 2
|
Charles River Stock May Gain From Extended CHDI Research Deal on HD
|
|
Jun 2
|
Charles River Laboratories to Present at William Blair and Jefferies Conferences
|
|
Jun 2
|
1 Value Stock with Impressive Fundamentals and 2 to Steer Clear Of
|
|
May 30
|
Charles River Laboratories International, Inc. (CRL): A Bull Case Theory
|
|
May 28
|
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
|
|
May 24
|
Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT
|
|
May 21
|
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
|
|
May 13
|
Understanding Charles River (CRL) Reliance on International Revenue
|
|
May 13
|
Charles River Laboratories to Present at Bank of America Health Care Conference
|
|
May 11
|
Earnings To Watch: Fortrea (FTRE) Reports Q1 Results Tomorrow
|
|
May 9
|
Eli Lilly extends Purdue alliance; EMA investigates Valneva shot
|
|
May 8
|
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
|
|
May 8
|
Charles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ...
|
|
Feb 21
|
Charles River Laboratories International Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 20
|
Charles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ...
|
|
Feb 20
|
Q4 2024 Charles River Laboratories International Inc Earnings Call
|
|
Feb 19
|
Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance
|
|
Feb 19
|
CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall
|
|
Feb 19
|
Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics
|
|
Feb 19
|
Charles River beats quarterly estimates on stable demand for drug development services
|